DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slipped 3.03% to $8.33 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 3.56% to 22,204.43 and Dow Jones Industrial Average falling 1.90% to 45,479.60.
This was the stock's third consecutive day of losses.
Novavax Inc. closed 37.56% below its 52-week high of $13.34, which the company reached on October 14th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.19% to $190.72, Pfizer Inc. $(PFE)$ fell 1.82% to $24.78, and Merck & Co. Inc. $(MRK)$ fell 1.73% to $85.99.
Trading volume (4.5 M) remained 2.1 million below its 50-day average volume of 6.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 10, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 10, 2025 17:27 ET (21:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.